You are here

Article Text

Article menu
Download PDFPDF
Correspondence
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

https://doi.org/10.1136/annrheumdis-2020-218075

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors HS-K, KK and AS: Literature search, data analysis, data interpretation, writing. IV and RH: Data collection, data interpretation, writing.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Linked Articles